256 related articles for article (PubMed ID: 24631448)
1. Statins, aspirin and risk of thromboembolic events in ovarian cancer patients.
Shai A; Rennert HS; Rennert G; Sagi S; Leviov M; Lavie O
Gynecol Oncol; 2014 May; 133(2):304-8. PubMed ID: 24631448
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
Goel R; Fleischman AN; Tan T; Sterbis E; Huang R; Higuera C; Parvizi J; Rothman RH
Bone Joint J; 2018 Jan; 100-B(1 Supple A):68-75. PubMed ID: 29292343
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
Rinaldo L; Brown DA; Bhargav AG; Rusheen AE; Naylor RM; Gilder HE; Monie DD; Youssef SJ; Parney IF
J Neurosurg; 2019 Jan; 132(1):10-21. PubMed ID: 30611138
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
[TBL] [Abstract][Full Text] [Related]
5. Statins, aspirin and risk of venous thromboembolic events in breast cancer patients.
Shai A; Rennert HS; Lavie O; Ballan-Haj M; Bitterman A; Steiner M; Keren S; Rennert G
J Thromb Thrombolysis; 2014 Jul; 38(1):32-8. PubMed ID: 24154915
[TBL] [Abstract][Full Text] [Related]
6. Incidence and Clinical Characteristic of Venous Thromboembolism in Gynecologic Oncology Patients attending King Chulalongkorn Memorial Hospital over a 10 Year Period.
Oranratanaphan S; Termrungruanglert W; Khemapech N
Asian Pac J Cancer Prev; 2015; 16(15):6705-9. PubMed ID: 26434898
[TBL] [Abstract][Full Text] [Related]
7. Dose-related effect of statins in venous thrombosis risk reduction.
Khemasuwan D; Chae YK; Gupta S; Carpio A; Yun JH; Neagu S; Lucca AB; Valsecchi ME; Mora JI
Am J Med; 2011 Sep; 124(9):852-9. PubMed ID: 21783169
[TBL] [Abstract][Full Text] [Related]
8. Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study.
Tagalakis V; Eberg M; Kahn S; Azoulay L
Thromb Haemost; 2016 Jun; 115(6):1220-8. PubMed ID: 26819144
[TBL] [Abstract][Full Text] [Related]
9. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
[TBL] [Abstract][Full Text] [Related]
10. The timing of venous thromboembolic events after spine surgery: a single-center experience with 6869 consecutive patients.
Cloney MB; Hopkins B; Dhillon ES; Dahdaleh NS
J Neurosurg Spine; 2018 Jan; 28(1):88-95. PubMed ID: 29125431
[TBL] [Abstract][Full Text] [Related]
11. Statins for the prevention of venous thromboembolism? a narrative review.
Sehdev A; Wanner N; Pendleton RC
Hosp Pract (1995); 2012 Aug; 40(3):13-8. PubMed ID: 23086090
[TBL] [Abstract][Full Text] [Related]
12. Early chemoprophylaxis is associated with decreased venous thromboembolism risk without concomitant increase in intraspinal hematoma expansion after traumatic spinal cord injury.
Chang R; Scerbo MH; Schmitt KM; Adams SD; Choi TJ; Wade CE; Holcomb JB
J Trauma Acute Care Surg; 2017 Dec; 83(6):1088-1094. PubMed ID: 28863085
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.
Cheung KL; Zakai NA; Callas PW; Howard G; Mahmoodi BK; Peralta CA; Judd SE; Kurella Tamura M; Cushman M
J Thromb Haemost; 2018 Sep; 16(9):1743-1752. PubMed ID: 29984467
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
15. Preinjury statin use and thromboembolic events in trauma: a 10-year retrospective evaluation.
McMahon RA; Fletcher JL; Aden JK; Holland SR; Trexler ST; Blackbourne LH
J Surg Res; 2018 Jun; 226():100-111. PubMed ID: 29661275
[TBL] [Abstract][Full Text] [Related]
16. Statins decrease the occurrence of venous thromboembolism in patients with cancer.
Khemasuwan D; Divietro ML; Tangdhanakanond K; Pomerantz SC; Eiger G
Am J Med; 2010 Jan; 123(1):60-5. PubMed ID: 20102993
[TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
[TBL] [Abstract][Full Text] [Related]
18. Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.
Zhou Q; Zhu C; Shen Z; Zhang T; Li M; Zhu J; Qin J; Xie Y; Zhang W; Chen R; Wang G; Qian L; Wu D; Nashan B; Zhou Y
Eur J Surg Oncol; 2020 May; 46(5):855-861. PubMed ID: 32001042
[TBL] [Abstract][Full Text] [Related]
19. Statins can benefit patients with primary membranous nephropathy on venous thromboembolism.
Zou P; Li H; Cai J; Chen Z; Li C; Li X
Ren Fail; 2021 Dec; 43(1):302-306. PubMed ID: 33583321
[TBL] [Abstract][Full Text] [Related]
20. Statin treatment and the risk of recurrent pulmonary embolism.
Biere-Rafi S; Hutten BA; Squizzato A; Ageno W; Souverein PC; de Boer A; Gerdes VE; Büller HR; Kamphuisen PW
Eur Heart J; 2013 Jun; 34(24):1800-6. PubMed ID: 23396492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
